Does nebivolol have renoprotective action in patients with chronic kidney disease conditions? An integrative review

Systemic arterial hypertension (SAH) is a chronic disease of multifactorial origin and one of the main risk factors for major adverse cardiovascular events (MACE), which are the leading causes of morbidity and mortality worldwide. The pharmacological treatment of SAH involves five main classes of dr...

Ausführliche Beschreibung

Bibliographische Detailangaben

Veröffentlicht in:	European journal of pharmacology 2021-08, Vol.905, p.174180-174180, Article 174180
Hauptverfasser:	Araújo Encinas, Jéssica Freitas, Foncesca Peiró, Carlos Henrique, Perez, Matheus Moreira, Santos Raimundo, Joyce Regina, de Gois, Katharyna Cardoso, Peres, Marina Cristina, Draghi, Patricia Ferrante, Costas Arcia, Catherine Giovanna, Simões, Diogo Pimenta, Murad, Neif, da Costa Aguiar Alves, Beatriz, Affonso Fonseca, Fernando Luiz, Luciano da Veiga, Glaucia
Format:	Artikel
Sprache:	eng
Schlagworte:	Antioxidant Hypertension Nebivolol Renal disease
Online-Zugang:	Volltext
Tags:	Tag hinzufügen Keine Tags, Fügen Sie den ersten Tag hinzu!